Call For Posters

 

• We invite submissions for Posters that address topics and issues involving antibody-mediated neurological diseases.
• We encourage you to submit your work by September 25th, 2024.
• A limited number of poster could be  selected and will be presented during the Workshop

Submit you work HERE

 

Overview

 

The International Workshop on Antibody-Mediated Neurological Diseases is set as a key event to update the medical-scientific community on the latest developments in the field of antibody-mediated neurological disorders. With a specific focus on conditions such as myasthenia gravis, autoimmune encephalitis, and neuromyelitis optica spectrum disorders, the workshop aims to provide a holistic understanding that ranges from pathogenesis to the latest innovations in diagnostic and therapeutic fields. Particular emphasis will be given to diagnostic challenges, through the analysis of complex clinical cases and the illustration of how new technologies are revolutionizing the study of autoimmune neurological diseases. The workshop intends to stimulate constructive and interdisciplinary dialogue, promoting integration between clinical practice and advanced biotechnologies.

The event promises to be a unique opportunity for multidisciplinary learning and for creating professional networks, essential to effectively respond to the challenges posed by antibody-mediated neurological diseases.

 

Endorsements

 

This educational activity is endorsed by:

 

Learning Objectives

 

 

• Provide a comprehensive update on the latest research and discoveries in antibody-mediated neurological diseases.
• Discuss in-depth advances in biomarkers, diagnostic techniques, and therapeutic strategies for these conditions.
• Analyze diagnostic challenges, including differential diagnoses, through the exploration of detailed clinical cases.
• Illustrate the use of new technologies in the study and management of autoimmune neurological diseases.
• Encourage collaboration and the exchange of ideas among professionals from various medical, scientific, and technological disciplines.

 

Target Audience

 

The workshop is designed for:

• Medical trainees and specialists in Neurology, Psychiatry, and Child Neuropsychiatry.
• Medical specialists in Ophthalmology, Infectious Diseases, Microbiology, Radiology, Pathological Anatomy, Anesthesia and Resuscitation, Hematology, and Oncology.
• PhD candidates and researchers in Neuroscience, Biologists, Biotechnologists, and Psychologists.
• Laboratory and neurophysiopathology technicians.
• Nurses specialized in neurosciences and neurological diseases.

 

Scientific Organizer

 

Raffaele Iorio
Department of Neuroscience Università Cattolica del Sacro Cuore Rome, Italy

 

CME Accreditation

 

The Programme has been submitted for CME accreditation to the European Accreditation Council for Continuing Medical Education (EACCME) and accredited by the Italian Ministry of Health by the CME provider SMM srl (Id. 5129) as follows:

 Event number: 425011  - CME Credits: 6

 

Venue

 

Auditorium Via Rieti
Via Rieti 13, Rome, Italy

 

Preliminary Programme

 

08:30 - 08.40 Welcome Address

P. Calabresi, Italy - A. Evoli, Italy - R. Iorio, Italy

Chairmen: P. Calabresi, Italy - R. Iorio, Italy

08.40-09.00 Keynote Speech: The role of B cells in Neurological Autoimmunity

K. O’Connor, USA

 

Session 1: Myasthenia Gravis
Chairmen: C. Antozzi, Italy - M.P. Giannoccaro, Italy

09.00-09.20 Diagnostic and Therapeutic Challenges in Myasthenia Gravis

A.Evoli, Italy

 

09.20-09.40 The role of complement activation in myasthenia gravis: looking for biomarkers

S. Hoffmann, Germany

 

09.40-10.00 Immunopathogenesis of MuSK-MG

MG. Huijbers, The Netherlands

 

10.00-10.20 Cellular immunotherapies for Myasthenia Gravis

A. Payne, USA

 

10.20-10.35 Q&A

 

10.35-10.55 Coffee Break

 

Session 2: Neuromyelitis Optica Spectrum Disorders (NMOSD)
Chairmen: S. Mariotto, Italy - E. Sechi, Italy

 

10.55-11.15 Immunopathogenesis of MOGAD and AQP4 Autoimmune Disorders: Insights for Improving Treatment Outcomes

R. Marignier, France

 

11.15-11.35 Diagnostic and therapeutic challenges in MOGAD and AQP4 autoimmunity

A. Cobo Calvo, Spain

 

11.35-11.55 Traditional and advanced Neuroimaging in MOGAD and AQP4 Autoimmunity

R. Cortese, Italy

 

11.55-12.10 Q&A

 

12.10-13.10 Lunch

 

Session 3: Autoimmune Encephalitis

Chairmen: M. Gastaldi, Italy - L. Zuliani, Italy

 

13.10-13.30 The Complex Interplay between Genetics and Environment in the pathogenesis of Autoimmune encephalitis

S. Muniz Castrillo, Spain

 

13.30-13.50 Pathogenic mechanisms of Autoimmune Encephalitis

M. Spatola, Spain

 

13.50-14.10 Human recombinant monoclonal antibodies and CAAR-T cells in autoimmune encephalitis

H. Pruss, Germany

 

14.10-14.30 Unity is Strength: how Collaboration Networks can advance the field of Autoimmune Encephalitis

F. Leypoldt, Germany

 

14.30-14.55 Q&A

 

14.55-15.15 Coffee Break

 

Session 4: Harnessing Novel Technologies to Unravel Neurological Autoimmunity

Chairmen: R. Iorio, Italy - A. Vogrig, Italy

 

15.15-15.35 Thymic organoids: opportunities and challenges to study central tolerance

L. Sangho, The Netherlands

 

15.35-15.55 The impact of structural biology on understanding the pathogenic mechanisms of autoimmune neurological diseases

C. Noviello, USA

 

15.55-16.15 Single-cell multiomics to investigate antibody-mediated neurological diseases

B. Schreiner, Switzerland

 

16.15-16.30 Q&A

16.30 Closing Remarks

 

16.40 End of the workshop

 

Acknowledgements